-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Eiger BioPharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2020 to Q4 2023.
- Eiger BioPharmaceuticals, Inc. Costs and Expenses for the quarter ending December 31, 2023 was $16.4M, a 39.6% decline year-over-year.
- Eiger BioPharmaceuticals, Inc. Costs and Expenses for the twelve months ending December 31, 2023 was $87.6M, a 17.6% decline year-over-year.
- Eiger BioPharmaceuticals, Inc. annual Costs and Expenses for 2023 was $87.6M, a 17.6% decline from 2022.
- Eiger BioPharmaceuticals, Inc. annual Costs and Expenses for 2022 was $106M, a 19.2% increase from 2021.
- Eiger BioPharmaceuticals, Inc. annual Costs and Expenses for 2021 was $89.1M, a 43.3% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)